Cargando…
Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country
AIM: To investigate peg-interferon (peg-IFN) and ribavirin (RBV) therapy in Myanmar and to predict sustained virologic response (SVR). METHODS: This single-center, open-label, study was conducted in Myanmar between 2009 and 2014. A total of 288 patients infected with HCV genotypes 1, 2, 3 and 6 were...
Autores principales: | Hlaing, Naomi Khaing Than, Banerjee, Debolina, Mitrani, Robert, Arker, Soe Htet, Win, Kyaw San, Tun, Nyan Lin, Thant, Zaw, Win, Khin Maung, Reddy, K Rajender |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116605/ https://www.ncbi.nlm.nih.gov/pubmed/27920482 http://dx.doi.org/10.3748/wjg.v22.i43.9613 |
Ejemplares similares
-
Burnout among house officers in Myanmar: A cross-sectional study
por: Lin, Kyaw San, et al.
Publicado: (2018) -
Trajectory of confirmed cases and deaths: fourth wave of COVID-19 epidemic in Myanmar
por: Htun, Ye Minn, et al.
Publicado: (2023) -
Cost estimates of COVID-19 clinical management in Myanmar
por: Thant, Phyu Win, et al.
Publicado: (2021) -
Seroprevalence and associated risk factors of Toxoplasma gondii infection among slaughterhouse workers in Yangon Region, Myanmar: A cross-sectional study
por: Sint, Nay Hein, et al.
Publicado: (2023) -
Surge of severe acute respiratory syndrome coronavirus 2 infections linked to single introduction of a virus strain in Myanmar, 2020
por: Nyunt, Myat Htut, et al.
Publicado: (2021)